0 CHECKOUT

NRT Smoking Cessation Aids in Costa Rica

  • ID: 1801673
  • June 2013
  • Region: Costa Rica
  • 18 pages
  • Euromonitor International

While Costa Rica’s authorities continued to approve and enforce harder anti-smoking regulations, which include new regulatory bans and higher taxation, the demand for NRT smoking cessation aids was limited in the country. This was largely due to the low product offer and restrictive unit prices. In general, the availability of such products remained poorly developed, especially in terms of products for different phases (which vary in terms of nicotine level) and the low understanding of how to...

The NRT Smoking Cessation Aids in Costa Rica report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

NRT SMOKING CESSATION AIDS IN COSTA RICA
Euromonitor International
June 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2007-2012
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2007-2012
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2007-2012
Table 4 NRT Gum Flavours: % Value Breakdown 2007-2012
Table 5 NRT Smoking Cessation Aids Company Shares 2008-2012
Table 6 NRT Smoking Cessation Aids Brand Shares 2009-2012
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
Executive Summary
Increased Competition and Macroeconomic Stability See Steady Value Growth
Segmentation and Added-value Features Drive New Product Development
International Players Continue To Dominate Sales
Chemists/pharmacies Is the Key Distribution Channel
New Active Ingredients Are Set To Boost Sales Over the Forecast Period
Key Trends and Developments
Economic Concern Puts Pressure on Sales of Added-value Products
Hectic Lifestyles Increase the Incidence of Stress-related Illnesses
Economic Uncertainty Threatens the Public Health System in Costa Rica
Generics Expand in Costa Rica
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 10 Life Expectancy at Birth 2007-2012
Market Data
Table 11 Sales of Consumer Health by Category: Value 2007-2012
Table 12 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 13 Consumer Health Company Shares 2008-2012
Table 14 Consumer Health Brand Shares 2009-2012
Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 17 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2011-2012
Definitions
Sources
Summary 2 Research Sources

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH